BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20452681)

  • 21. Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors.
    Badn W; Visse E; Darabi A; Smith KE; Salford LG; Siesjö P
    J Immunol; 2007 Sep; 179(6):4231-8. PubMed ID: 17785863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy for glioma: from illusion to realistic prospects?
    Dietrich PY; Dutoit V; Walker PR
    Am Soc Clin Oncol Educ Book; 2014; ():51-9. PubMed ID: 24857060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery.
    Graf MR; Prins RM; Poulsen GA; Merchant RE
    J Neuroimmunol; 2003 Jul; 140(1-2):49-60. PubMed ID: 12864971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free mice.
    Forghani P; Harris W; Giver CR; Mirshafiey A; Galipeau J; Waller EK
    PLoS One; 2013; 8(7):e64837. PubMed ID: 23843936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.
    Clavreul A; Delhaye M; Jadaud E; Menei P
    J Neurooncol; 2006 Aug; 79(1):9-17. PubMed ID: 16575532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma.
    Insug O; Ku G; Ertl HC; Blaszczyk-Thurin M
    Anticancer Res; 2002; 22(2A):613-21. PubMed ID: 12014629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
    Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
    Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.
    Veltman JD; Lambers ME; van Nimwegen M; Hendriks RW; Hoogsteden HC; Aerts JG; Hegmans JP
    BMC Cancer; 2010 Aug; 10():464. PubMed ID: 20804550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOX2 immunity and tissue resident memory in children and young adults with glioma.
    Vasquez JC; Huttner A; Zhang L; Marks A; Chan A; Baehring JM; Kahle KT; Dhodapkar KM
    J Neurooncol; 2017 Aug; 134(1):41-53. PubMed ID: 28620836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
    Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
    J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models.
    Alghamri MS; Kamran N; Kadiyala P; Lowenstein PR; Castro MG
    Methods Enzymol; 2020; 632():215-228. PubMed ID: 32000897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
    Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
    Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
    Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
    J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of tumor infiltrating lymphocytes in the immunopathology of gliomas].
    Geppert A; Patt S
    Neurol Neurochir Pol; 2001; 35(4):661-6. PubMed ID: 11783408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.
    Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S
    Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.
    Tzeng JJ; Barth RF; Orosz CG; James SM
    Cancer Res; 1991 May; 51(9):2373-8. PubMed ID: 2015600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.
    Zhou Q; Xiao H; Liu Y; Peng Y; Hong Y; Yagita H; Chandler P; Munn DH; Mellor A; Fu N; He Y
    J Immunol; 2010 Nov; 185(9):5082-92. PubMed ID: 20926790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.